BioPharma - Past Private Portfolio

Company Area Exit Acquirer / Exchange

Acusphere

Drug development
Cardiovascular 		IPO 2003 NASDAQ

Adnexus Therapeutics

Drug development
Oncology 		Trade sale
2007 		BMS

Agensys

 Drug development
Oncology 		Trade sale
2007 		Astellas

Anadys Pharmaceuticals

Drug development
Anti-infectives / Oncology 		IPO
2004 		NASDAQ

Anthera

Drug development
Cardiovascular / Inflammation 		IPO
2010 		NASDAQ

Arpida

Drug development
Anti-infectives 		IPO
2005 		SIX

Aspreva Pharmaceuticals

Drug development
Immunology 		IPO
2005 		NASDAQ

Axovan

 Drug development
Cardiovascular 		Trade sale
2004 		Actelion

Basilea Pharmaceutica

Drug development
Anti-infectives 		IPO
2004 		SIX

Biovitrum

Drug development
Hematology / Metabolic 		IPO 2006 OMX
Stockholm

Cardion

 Drug development
Cardiovascular 		Trade sale
2003 		Roche

China Nuokang

Drug development
Cardiovascular 		IPO
2009 		NASDAQ

Corgentech

Drug development
Neurology 		IPO
2004 		NASDAQ

Cytokinetics

Drug development
Metabolic /Oncology 		IPO
2004 		NASDAQ

Cytos Biotechnology

Drug development
Immunology 		IPO
2002 		SIX

ESBATech

Drug development
Ophthalmology 		Trade sale
2009 		Alcon

Genesoft Pharmaceuticals

 Drug development
Anti-infectives 		Trade sale
2003 		Genome Therapeutics

ICAgen

Drug development
Neurology / Inflammation 		IPO
2004 		NASDAQ

Infinity Pharmaceuticals

Drug development
Oncology 		IPO
2006 		NASDAQ

Mediservice

Services
Pharmacy 		Trade sale
2007 		Galenica

Micromet

Drug development
Oncology 		IPO
2006 		NASDAQ

Newron Pharmaceuticals

Drug development
Neurology 		IPO
2006 		SIX

Panomics

Life science technology
Assays 		Trade sale
2008 		Affymetrix

Renovis

 Drug development
Neurology 		IPO
2003 		NASDAQ

Sloning BioTechnology

Life science technology Trade sale
2010 		Boston Scientific

Sunesis Pharmaceuticals

Drug development
Oncology 		IPO
2005 		NASDAQ

Syrrx

 Drug discovery
Metabolic 		Trade sale
2005 		Takeda

Transform Pharmaceuticals

Drug manufacturing
Formulations 		Trade sale
2005 		Johnson &
Johnson

Xenoport

Drug development
Neurology 		IPO
2005 		NASDAQ

Zycos

 Drug development
Anti-infectives / Oncology 		Trade sale
2004 		MGI Pharma
 
 
 

© HBM Partners AG 18.05.2012